APO Research
Talk to an analyst

APO RESEARCH · REPORT

Propofol Emulsion Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Propofol Emulsion Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026199 pages

Choose your research edition.

Industry ResearchPropofol Emulsion Injection Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Propofol Emulsion Injection Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Propofol Emulsion Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Propofol Emulsion Injection Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Propofol Emulsion Injection Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Propofol Emulsion Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Propofol Emulsion Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Propofol Emulsion Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Propofol Emulsion Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Propofol Emulsion Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Propofol Emulsion Injection include Xian Libang Pharmaceutical, Teva, Sandoz, Jiangsu Nhwa Group, Pfizer, Sinopharm Guorui Pharm, Guangdong Jiabo Pharmaceutical, Fresenius Kabi and Baxter, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Propofol Emulsion Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Propofol Emulsion Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Propofol Emulsion Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Propofol Emulsion Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Propofol Emulsion Injection Segment by Company

Xian Libang Pharmaceutical

Teva

Sandoz

Jiangsu Nhwa Group

Pfizer

Sinopharm Guorui Pharm

Guangdong Jiabo Pharmaceutical

Fresenius Kabi

Baxter

AstraZeneca

Sagent

Dr. Reddy's

B Braun

Propofol Emulsion Injection Segment by Type

20ml/vial

50ml/vial

100ml/vial

Propofol Emulsion Injection Segment by Application

Hospital

Clinics

Recovery Center

Propofol Emulsion Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Propofol Emulsion Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Propofol Emulsion Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Propofol Emulsion Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Propofol Emulsion Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Propofol Emulsion Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Propofol Emulsion Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Propofol Emulsion Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Propofol Emulsion Injection Industry Trends Table 2. Propofol Emulsion Injection Industry Drivers Table 3. Propofol Emulsion Injection Industry Opportunities and Challenges Table 4. Propofol Emulsion Injection Industry Restraints Table 5. Global Propofol Emulsion Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Propofol Emulsion Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Propofol Emulsion Injection Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Propofol Emulsion Injection Sales Market Share by Manufacturers Table 9. Global Propofol Emulsion Injection Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Propofol Emulsion Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Propofol Emulsion Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Propofol Emulsion Injection Manufacturers, Product Type & Application Table 13. Global Propofol Emulsion Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Propofol Emulsion Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 20ml/vial Table 17. Major Manufacturers of 50ml/vial Table 18. Major Manufacturers of 100ml/vial Table 19. Global Propofol Emulsion Injection Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 20. Global Propofol Emulsion Injection Sales by Type (2021-2026) & (W Units) Table 21. Global Propofol Emulsion Injection Sales by Type (2027-2032) & (W Units) Table 22. Global Propofol Emulsion Injection Sales Market Share by Type (2021-2026) Table 23. Global Propofol Emulsion Injection Sales Market Share by Type (2027-2032) Table 24. Global Propofol Emulsion Injection Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 25. Global Propofol Emulsion Injection Revenue by Type (2021-2026) & (W Units) Table 26. Global Propofol Emulsion Injection Revenue by Type (2027-2032) & (W Units) Table 27. Global Propofol Emulsion Injection Revenue Market Share by Type (2021-2026) Table 28. Global Propofol Emulsion Injection Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Clinics Table 31. Major Manufacturers of Recovery Center Table 32. Global Propofol Emulsion Injection Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 33. Global Propofol Emulsion Injection Sales by Application (2021-2026) & (W Units) Table 34. Global Propofol Emulsion Injection Sales by Application (2027-2032) & (W Units) Table 35. Global Propofol Emulsion Injection Sales Market Share by Application (2021-2026) Table 36. Global Propofol Emulsion Injection Sales Market Share by Application (2027-2032) Table 37. Global Propofol Emulsion Injection Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 38. Global Propofol Emulsion Injection Revenue by Application (2021-2026) & (W Units) Table 39. Global Propofol Emulsion Injection Revenue by Application (2027-2032) & (W Units) Table 40. Global Propofol Emulsion Injection Revenue Market Share by Application (2021-2026) Table 41. Global Propofol Emulsion Injection Revenue Market Share by Application (2027-2032) Table 42. Global Propofol Emulsion Injection Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 43. Global Propofol Emulsion Injection Sales by Region (2021-2026) & (W Units) Table 44. Global Propofol Emulsion Injection Sales Market Share by Region (2021-2026) Table 45. Global Propofol Emulsion Injection Sales Forecasted by Region (2027-2032) & (W Units) Table 46. Global Propofol Emulsion Injection Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Propofol Emulsion Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 48. North America Propofol Emulsion Injection Sales by Country (2021-2026) & (W Units) Table 49. North America Propofol Emulsion Injection Sales by Country (2027-2032) & (W Units) Table 50. Europe Propofol Emulsion Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 51. Europe Propofol Emulsion Injection Sales by Country (2021-2026) & (W Units) Table 52. Europe Propofol Emulsion Injection Sales by Country (2027-2032) & (W Units) Table 53. Asia Pacific Propofol Emulsion Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 54. Asia Pacific Propofol Emulsion Injection Sales by Country (2021-2026) & (W Units) Table 55. Asia Pacific Propofol Emulsion Injection Sales by Country (2027-2032) & (W Units) Table 56. South America, Middle East and Africa Propofol Emulsion Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 57. South America, Middle East and Africa Propofol Emulsion Injection Sales by Country (2021-2026) & (W Units) Table 58. South America, Middle East and Africa Propofol Emulsion Injection Sales by Country (2027-2032) & (W Units) Table 59. Global Propofol Emulsion Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Propofol Emulsion Injection Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Propofol Emulsion Injection Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Propofol Emulsion Injection Revenue Market Share by Region (2021-2026) Table 63. Global Propofol Emulsion Injection Revenue Market Share by Region (2027-2032) Table 64. Xian Libang Pharmaceutical Company Information Table 65. Xian Libang Pharmaceutical Business Overview Table 66. Xian Libang Pharmaceutical Propofol Emulsion Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Xian Libang Pharmaceutical Propofol Emulsion Injection Product Portfolio Table 68. Xian Libang Pharmaceutical Recent Development Table 69. Teva Company Information Table 70. Teva Business Overview Table 71. Teva Propofol Emulsion Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Teva Propofol Emulsion Injection Product Portfolio Table 73. Teva Recent Development Table 74. Sandoz Company Information Table 75. Sandoz Business Overview Table 76. Sandoz Propofol Emulsion Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Sandoz Propofol Emulsion Injection Product Portfolio Table 78. Sandoz Recent Development Table 79. Jiangsu Nhwa Group Company Information Table 80. Jiangsu Nhwa Group Business Overview Table 81. Jiangsu Nhwa Group Propofol Emulsion Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Jiangsu Nhwa Group Propofol Emulsion Injection Product Portfolio Table 83. Jiangsu Nhwa Group Recent Development Table 84. Pfizer Company Information Table 85. Pfizer Business Overview Table 86. Pfizer Propofol Emulsion Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Pfizer Propofol Emulsion Injection Product Portfolio Table 88. Pfizer Recent Development Table 89. Sinopharm Guorui Pharm Company Information Table 90. Sinopharm Guorui Pharm Business Overview Table 91. Sinopharm Guorui Pharm Propofol Emulsion Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Sinopharm Guorui Pharm Propofol Emulsion Injection Product Portfolio Table 93. Sinopharm Guorui Pharm Recent Development Table 94. Guangdong Jiabo Pharmaceutical Company Information Table 95. Guangdong Jiabo Pharmaceutical Business Overview Table 96. Guangdong Jiabo Pharmaceutical Propofol Emulsion Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Guangdong Jiabo Pharmaceutical Propofol Emulsion Injection Product Portfolio Table 98. Guangdong Jiabo Pharmaceutical Recent Development Table 99. Fresenius Kabi Company Information Table 100. Fresenius Kabi Business Overview Table 101. Fresenius Kabi Propofol Emulsion Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Fresenius Kabi Propofol Emulsion Injection Product Portfolio Table 103. Fresenius Kabi Recent Development Table 104. Baxter Company Information Table 105. Baxter Business Overview Table 106. Baxter Propofol Emulsion Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Baxter Propofol Emulsion Injection Product Portfolio Table 108. Baxter Recent Development Table 109. AstraZeneca Company Information Table 110. AstraZeneca Business Overview Table 111. AstraZeneca Propofol Emulsion Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. AstraZeneca Propofol Emulsion Injection Product Portfolio Table 113. AstraZeneca Recent Development Table 114. Sagent Company Information Table 115. Sagent Business Overview Table 116. Sagent Propofol Emulsion Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Sagent Propofol Emulsion Injection Product Portfolio Table 118. Sagent Recent Development Table 119. Dr. Reddy's Company Information Table 120. Dr. Reddy's Business Overview Table 121. Dr. Reddy's Propofol Emulsion Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Dr. Reddy's Propofol Emulsion Injection Product Portfolio Table 123. Dr. Reddy's Recent Development Table 124. B Braun Company Information Table 125. B Braun Business Overview Table 126. B Braun Propofol Emulsion Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. B Braun Propofol Emulsion Injection Product Portfolio Table 128. B Braun Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. Propofol Emulsion Injection Distributors List Table 132. Propofol Emulsion Injection Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Propofol Emulsion Injection Product Image Figure 2. Global Propofol Emulsion Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Propofol Emulsion Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Propofol Emulsion Injection Sales (2021-2032) & (W Units) Figure 5. Global Propofol Emulsion Injection Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Propofol Emulsion Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 20ml/vial Image Figure 9. 50ml/vial Image Figure 10. 100ml/vial Image Figure 11. Global Propofol Emulsion Injection Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 12. Global Propofol Emulsion Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Propofol Emulsion Injection Sales Market Share by Type (2021-2032) Figure 14. Global Propofol Emulsion Injection Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 15. Global Propofol Emulsion Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Propofol Emulsion Injection Revenue Market Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinics Image Figure 19. Recovery Center Image Figure 20. Global Propofol Emulsion Injection Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 21. Global Propofol Emulsion Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Propofol Emulsion Injection Sales Market Share by Application (2021-2032) Figure 23. Global Propofol Emulsion Injection Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 24. Global Propofol Emulsion Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Propofol Emulsion Injection Revenue Market Share by Application (2021-2032) Figure 26. North America Propofol Emulsion Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 27. North America Propofol Emulsion Injection Sales Market Share by Country (2021-2032) Figure 28. U.S. Propofol Emulsion Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 29. Canada Propofol Emulsion Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 30. Mexico Propofol Emulsion Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 31. Europe Propofol Emulsion Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 32. Europe Propofol Emulsion Injection Sales Market Share by Country (2021-2032) Figure 33. Germany Propofol Emulsion Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 34. France Propofol Emulsion Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 35. U.K. Propofol Emulsion Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Italy Propofol Emulsion Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 37. Netherlands Propofol Emulsion Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 38. Asia Pacific Propofol Emulsion Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 39. Asia Pacific Propofol Emulsion Injection Sales Market Share by Country (2021-2032) Figure 40. China Propofol Emulsion Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 41. Japan Propofol Emulsion Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 42. South Korea Propofol Emulsion Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 43. Southeast Asia Propofol Emulsion Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 44. India Propofol Emulsion Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 45. Australia Propofol Emulsion Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 46. South America, Middle East and Africa Propofol Emulsion Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 47. South America, Middle East and Africa Propofol Emulsion Injection Sales Market Share by Country (2021-2032) Figure 48. Brazil Propofol Emulsion Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 49. South Africa Propofol Emulsion Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 50. Saudi Arabia Propofol Emulsion Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 51. Turkey Propofol Emulsion Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 52. Argentina Propofol Emulsion Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 53. UAE Propofol Emulsion Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Egypt Propofol Emulsion Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Chile Propofol Emulsion Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 56. Global Propofol Emulsion Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Propofol Emulsion Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Propofol Emulsion Injection Revenue (2021-2032) & (US$ Million) Figure 59. North America Propofol Emulsion Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Propofol Emulsion Injection Revenue (2021-2032) & (US$ Million) Figure 61. Europe Propofol Emulsion Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Propofol Emulsion Injection Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Propofol Emulsion Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Propofol Emulsion Injection Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Propofol Emulsion Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Propofol Emulsion Injection Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Propofol Emulsion Injection Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 20ml/vial
  • 50ml/vial
  • 100ml/vial
Applications
  • Hospital
  • Clinics
  • Recovery Center
Companies covered
  • Xian Libang Pharmaceutical
  • Teva
  • Sandoz
  • Jiangsu Nhwa Group
  • Pfizer
  • Sinopharm Guorui Pharm
  • Guangdong Jiabo Pharmaceutical
  • Fresenius Kabi
  • Baxter
  • AstraZeneca
  • Sagent
  • Dr. Reddy's
  • B Braun

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Propofol Emulsion Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Propofol Emulsion Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Propofol Emulsion Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Propofol Emulsion Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Propofol Emulsion Injection Market Dynamics
  1. 2.1 Propofol Emulsion Injection Industry Trends
  2. 2.2 Propofol Emulsion Injection Industry Drivers
  3. 2.3 Propofol Emulsion Injection Industry Opportunities and Challenges
  4. 2.4 Propofol Emulsion Injection Industry Restraints
3 Propofol Emulsion Injection Market by Manufacturers
  1. 3.1 Global Propofol Emulsion Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Propofol Emulsion Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Propofol Emulsion Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Propofol Emulsion Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Propofol Emulsion Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Propofol Emulsion Injection Manufacturers, Product Type & Application
  7. 3.7 Global Propofol Emulsion Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Propofol Emulsion Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Propofol Emulsion Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Propofol Emulsion Injection Tier 1, Tier 2, and Tier 3
4 Propofol Emulsion Injection Market by Type
  1. 4.1 Propofol Emulsion Injection Type Introduction
  2. 4.1.1 20ml/vial
  3. 4.1.2 50ml/vial
  4. 4.1.3 100ml/vial
  5. 4.2 Global Propofol Emulsion Injection Sales by Type
  6. 4.2.1 Global Propofol Emulsion Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Propofol Emulsion Injection Sales by Type (2021-2032)
  8. 4.2.3 Global Propofol Emulsion Injection Sales Market Share by Type (2021-2032)
  9. 4.3 Global Propofol Emulsion Injection Revenue by Type
  10. 4.3.1 Global Propofol Emulsion Injection Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Propofol Emulsion Injection Revenue by Type (2021-2032)
  12. 4.3.3 Global Propofol Emulsion Injection Revenue Market Share by Type (2021-2032)
5 Propofol Emulsion Injection Market by Application
  1. 5.1 Propofol Emulsion Injection Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinics
  4. 5.1.3 Recovery Center
  5. 5.2 Global Propofol Emulsion Injection Sales by Application
  6. 5.2.1 Global Propofol Emulsion Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Propofol Emulsion Injection Sales by Application (2021-2032)
  8. 5.2.3 Global Propofol Emulsion Injection Sales Market Share by Application (2021-2032)
  9. 5.3 Global Propofol Emulsion Injection Revenue by Application
  10. 5.3.1 Global Propofol Emulsion Injection Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Propofol Emulsion Injection Revenue by Application (2021-2032)
  12. 5.3.3 Global Propofol Emulsion Injection Revenue Market Share by Application (2021-2032)
6 Global Propofol Emulsion Injection Sales by Region
  1. 6.1 Global Propofol Emulsion Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Propofol Emulsion Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Propofol Emulsion Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Propofol Emulsion Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Propofol Emulsion Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Propofol Emulsion Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Propofol Emulsion Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Propofol Emulsion Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Propofol Emulsion Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Propofol Emulsion Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Propofol Emulsion Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Propofol Emulsion Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Propofol Emulsion Injection Revenue by Region
  1. 7.1 Global Propofol Emulsion Injection Revenue by Region
  2. 7.1.1 Global Propofol Emulsion Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Propofol Emulsion Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Propofol Emulsion Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Propofol Emulsion Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Propofol Emulsion Injection Revenue (2021-2032)
  8. 7.2.2 North America Propofol Emulsion Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Propofol Emulsion Injection Revenue (2021-2032)
  11. 7.3.2 Europe Propofol Emulsion Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Propofol Emulsion Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Propofol Emulsion Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Propofol Emulsion Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Propofol Emulsion Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Xian Libang Pharmaceutical
  2. 8.1.1 Xian Libang Pharmaceutical Company Information
  3. 8.1.2 Xian Libang Pharmaceutical Business Overview
  4. 8.1.3 Xian Libang Pharmaceutical Propofol Emulsion Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Xian Libang Pharmaceutical Propofol Emulsion Injection Product Portfolio
  6. 8.1.5 Xian Libang Pharmaceutical Recent Developments
  7. 8.2 Teva
  8. 8.2.1 Teva Company Information
  9. 8.2.2 Teva Business Overview
  10. 8.2.3 Teva Propofol Emulsion Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Teva Propofol Emulsion Injection Product Portfolio
  12. 8.2.5 Teva Recent Developments
  13. 8.3 Sandoz
  14. 8.3.1 Sandoz Company Information
  15. 8.3.2 Sandoz Business Overview
  16. 8.3.3 Sandoz Propofol Emulsion Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sandoz Propofol Emulsion Injection Product Portfolio
  18. 8.3.5 Sandoz Recent Developments
  19. 8.4 Jiangsu Nhwa Group
  20. 8.4.1 Jiangsu Nhwa Group Company Information
  21. 8.4.2 Jiangsu Nhwa Group Business Overview
  22. 8.4.3 Jiangsu Nhwa Group Propofol Emulsion Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Jiangsu Nhwa Group Propofol Emulsion Injection Product Portfolio
  24. 8.4.5 Jiangsu Nhwa Group Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Propofol Emulsion Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Propofol Emulsion Injection Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
  31. 8.6 Sinopharm Guorui Pharm
  32. 8.6.1 Sinopharm Guorui Pharm Company Information
  33. 8.6.2 Sinopharm Guorui Pharm Business Overview
  34. 8.6.3 Sinopharm Guorui Pharm Propofol Emulsion Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sinopharm Guorui Pharm Propofol Emulsion Injection Product Portfolio
  36. 8.6.5 Sinopharm Guorui Pharm Recent Developments
  37. 8.7 Guangdong Jiabo Pharmaceutical
  38. 8.7.1 Guangdong Jiabo Pharmaceutical Company Information
  39. 8.7.2 Guangdong Jiabo Pharmaceutical Business Overview
  40. 8.7.3 Guangdong Jiabo Pharmaceutical Propofol Emulsion Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Guangdong Jiabo Pharmaceutical Propofol Emulsion Injection Product Portfolio
  42. 8.7.5 Guangdong Jiabo Pharmaceutical Recent Developments
  43. 8.8 Fresenius Kabi
  44. 8.8.1 Fresenius Kabi Company Information
  45. 8.8.2 Fresenius Kabi Business Overview
  46. 8.8.3 Fresenius Kabi Propofol Emulsion Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Fresenius Kabi Propofol Emulsion Injection Product Portfolio
  48. 8.8.5 Fresenius Kabi Recent Developments
  49. 8.9 Baxter
  50. 8.9.1 Baxter Company Information
  51. 8.9.2 Baxter Business Overview
  52. 8.9.3 Baxter Propofol Emulsion Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Baxter Propofol Emulsion Injection Product Portfolio
  54. 8.9.5 Baxter Recent Developments
  55. 8.10 AstraZeneca
  56. 8.10.1 AstraZeneca Company Information
  57. 8.10.2 AstraZeneca Business Overview
  58. 8.10.3 AstraZeneca Propofol Emulsion Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 AstraZeneca Propofol Emulsion Injection Product Portfolio
  60. 8.10.5 AstraZeneca Recent Developments
  61. 8.11 Sagent
  62. 8.11.1 Sagent Company Information
  63. 8.11.2 Sagent Business Overview
  64. 8.11.3 Sagent Propofol Emulsion Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sagent Propofol Emulsion Injection Product Portfolio
  66. 8.11.5 Sagent Recent Developments
  67. 8.12 Dr. Reddy's
  68. 8.12.1 Dr. Reddy's Company Information
  69. 8.12.2 Dr. Reddy's Business Overview
  70. 8.12.3 Dr. Reddy's Propofol Emulsion Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Dr. Reddy's Propofol Emulsion Injection Product Portfolio
  72. 8.12.5 Dr. Reddy's Recent Developments
  73. 8.13 B Braun
  74. 8.13.1 B Braun Company Information
  75. 8.13.2 B Braun Business Overview
  76. 8.13.3 B Braun Propofol Emulsion Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 B Braun Propofol Emulsion Injection Product Portfolio
  78. 8.13.5 B Braun Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Propofol Emulsion Injection Value Chain Analysis
  2. 9.1.1 Propofol Emulsion Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Propofol Emulsion Injection Production Mode & Process
  6. 9.2 Propofol Emulsion Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Propofol Emulsion Injection Distributors
  9. 9.2.3 Propofol Emulsion Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst